Preoperative aspirin resistance does not increase myocardial injury during off-pump coronary artery bypass surgery

Journal of Korean Medical Science

Volumn 26, Issue 8, 2011, Pages 1041-1046

  Kim, Hyun Joo ^a   Lee, Jung Man ^a   Seo, Jeong Hwa ^a   Kim, Jun Hyeon ^a   Hong, Deok Man ^a   Bahk, Jae Hyon ^a   Kim, Ki Bong ^a   Jeon, Yunseok ^a  

^a Seoul National University Hospital   (South Korea)

Author keywords

Aspirin; Coronary artery bypass; Drug resistance; Hemorrhage; Off Pump; Troponin I

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; TROPONIN I;

AGED; ARTICLE; BLOOD; COHORT ANALYSIS; CORONARY ARTERY DISEASE; DRUG RESISTANCE; FEMALE; HEART INFARCTION; HUMAN; MALE; METHODOLOGY; MIDDLE AGED; OFF PUMP CORONARY SURGERY; POSTOPERATIVE HEMORRHAGE; PREOPERATIVE CARE; PROSPECTIVE STUDY; REPERFUSION INJURY; STROKE;

AGED; ASPIRIN; COHORT STUDIES; CORONARY ARTERY BYPASS, OFF-PUMP; CORONARY DISEASE; DRUG RESISTANCE; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY; PLATELET AGGREGATION INHIBITORS; POSTOPERATIVE HEMORRHAGE; PREOPERATIVE CARE; PROSPECTIVE STUDIES; STROKE; TROPONIN I;

EID: 80052669497     PISSN: 10118934     EISSN: 15986357     Source Type: Journal    
DOI: 10.3346/jkms.2011.26.8.1041     Document Type: Article

References (29)

1. Vane JR. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nat New Biol 1971; 231: 232-5.
2. Goldman S, Copeland J, Moritz T, Henderson W, Zadina K, Ovitt T, Doherty J, Read R, Chesler E, Sako Y. Improvement in early saphenous vein graft patency after coronary artery bypass surgery with antiplatelet therapy: results of a Veterans Administration Cooperative Study. Circulation 1988; 77: 1324-32.
3. Goldman S, Copeland J, Moritz T, Henderson W, Zadina K, Ovitt T, Kern KB, Sethi G, Sharma GV, Khuri S. Long-term graft patency (3 years) after coronary artery surgery. Effects of aspirin: results of a VA Cooperative study. Circulation 1994; 89: 1138-43.
4. Mangano DT. Aspirin and mortality from coronary bypass surgery. N Engl J Med 2002; 347: 1309-17.
5. Gum PA, Kottke-Marchant K, Welsh PA, White J, Topol EJ. A prospective, blinded determination of the natural history of aspirin resistance among stable patients with cardiovascular disease. J Am Coll Cardiol 2003; 41: 961-5.
6. Pamukcu B, Oflaz H, Onur I, Oncul A, Ozcan M, Umman B, Mercanoglu F, Meric M, Nisanci Y. Clinical relevance of aspirin resistance in patients with stable coronary artery disease: a prospective follow-up study (PRO- SPECTAR). Blood Coagul Fibrinolysis 2007; 18: 187-92.
7. Poston RS, Gu J, Brown JM, Gammie JS, White C, Nie L, Pierson RN 3rd, Griffith BP. Endothelial injury and acquired aspirin resistance as promoters of regional thrombin formation and early vein graft failure after coronary artery bypass grafting. J Thorac Cardiovasc Surg 2006; 131: 122-30.
8. Yilmaz MB, Balbay Y, Caldir V, Ayaz S, Guray Y, Guray U, Korkmaz S. Late saphenous vein graft occlusion in patients with coronary bypass: possible role of aspirin resistance. Thromb Res 2005; 115: 25-9.
9. Peivandi AA, Dahm M, Hake U, Hafner G, Opfermann UT, Loos AH, Tzanova I, Oelert H. Patterns and diagnostic value of cardiac troponin I vs. troponin T and CKMB after OPCAB surgery. Thorac Cardiovasc Surg 2001; 49: 137-43.
10. Peivandi AA, Dahm M, Opfermann UT, Peetz D, Doerr F, Loos A, Oelert H. Comparison of cardiac troponin I versus T and creatine kinase MB after coronary artery bypass grafting in patients with and without perioperative myocardial infarction. Herz 2004; 29: 658-64.
11. van Werkum JW, Harmsze AM, Elsenberg EH, Bouman HJ, ten Berg JM, Hackeng CM. The use of the VerifyNow system to monitor antiplatelet therapy: a review of the current evidence. Platelets 2008; 19: 479-88.
12. Gavaghan TP, Gebski V, Baron DW. Immediate postoperative aspirin improves vein graft patency early and late after coronary artery bypass graft surgery. A placebo-controlled, randomized study. Circulation 1991; 83: 1526-33.
13. Dacey LJ, Munoz JJ, Johnson ER, Leavitt BJ, Maloney CT, Morton JR, Olmstead EM, Birkmeyer JD, O'Connor GT; Northern New England Cardiovascular Disease Study Group. Effect of preoperative aspirin use on mortality in coronary artery bypass grafting patients. Ann Thorac Surg 2000; 70: 1986-90.
14. Møller CH, Steinbrüchel DA. Platelet function after coronary artery bypass grafting: is there a procoagulant activity after off-pump compared with on-pump surgery? Scand Cardiovasc J 2003; 37: 149-53.
15. Zimmermann N, Kurt M, Wenk A, Winter J, Gams E, Hohlfeld T. Is cardiopulmonary bypass a reason for aspirin resistance after coronary artery bypass grafting? Eur J Cardiothorac Surg 2005; 27: 606-10.
16. Suwalski G, Suwalski P, Filipiak KJ, Postuła M, Majstrak F, Opolski G. The effect of off-pump coronary artery bypass grafting on platelet activation in patients on aspirin therapy until surgery day. Eur J Cardiothorac Surg 2008; 34: 365-9.
17. Chen ZM, Jiang LX, Chen YP, Xie JX, Pan HC, Peto R, Collins R, Liu LS.; COMMIT (ClOpidogrel and Metoprolol in Myocardial Infarction Trial) collaborative group. Addition of clopidogrel to aspirin in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial. Lancet 2005; 366: 1607-21.
18. Steinhubl SR, Berger PB, Mann JT 3rd, Fry ET, DeLago A, Wilmer C, Topol EJ.; CREDO Investigators. Clopidogrel for the Reduction of Events During Observation. Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial. JAMA 2002; 288: 2411-20.
19. Gasparyan AY, Watson T, Lip GY. The role of aspirin in cardiovascular prevention: implications of aspirin resistance. J Am Coll Cardiol 2008; 51: 1829-43.
20. Srinivasan AK, Grayson AD, Pullan DM, Fabri BM, Dihmis WC. Effect of preoperative aspirin use in off-pump coronary artery bypass operations. Ann Thorac Surg 2003; 76: 41-5.
21. Gulbins H, Malkoc A, Ennker IC, Ennker J. Preoperative platelet inhibition with ASA does not influence postoperative blood loss following coronary artery bypass grafting. Thorac Cardiovasc Surg 2009; 57: 18-21.
22. Matsuura K, Imamaki M, Ishida A, Shimura H, Miyazaki M. The effect of preoperative aspirin administration on postoperative level of von Willebrand factor in off-pump coronary artery bypass surgery. Heart Vessels 2009; 24: 169-74.
23. Kallis P, Tooze JA, Talbot S, Cowans D, Bevan DH, Treasure T. Pre-operative aspirin decreases platelet aggregation and increases post-operative blood loss: a prospective, randomised, placebo controlled, double-blind clinical trial in 100 patients with chronic stable angina. Eur J Cardiothorac Surg 1994; 8: 404-9.
24. Morawski W, Sanak M, Cisowski M, Szczeklik M, Szczeklik W, Dropinski J, Waclawczyk T, Ulczok R, Bochenek A. Prediction of the excessive perioperative bleeding in patients undergoing coronary artery bypass grafting: role of aspirin and platelet glycoprotein IIIa polymorphism. J Thorac Cardiovasc Surg 2005; 130: 791-6.
25. Berger JS, Frye CB, Harshaw Q, Edwards FH, Steinhubl SR, Becker RC. Impact of clopidogrel in patients with acute coronary syndromes requiring coronary artery bypass surgery: a multicenter analysis. J Am Coll Cardiol 2008; 52: 1693-701.
26. Maltais S, Perrault LP, Do QB. Effect of clopidogrel on bleeding and transfusions after off-pump coronary artery bypass graft surgery: impact of discontinuation prior to surgery. Eur J Cardiothorac Surg 2008; 34: 127-31.
27. Chan V, Kulik A, Bourke ME, Ressler L, Mesana TG, Ruel M. Clopidogrel is safe early after on- and off-pump coronary artery bypass surgery. J Card Surg 2007; 22: 493-7.
28. Hankey GJ, Eikelboom JW. Aspirin resistance. Lancet 2006; 367: 606-17.
29. Martin CP, Talbert RL. Aspirin resistance: an evaluation of current evidence and measurement methods. Pharmacotherapy 2005; 25: 942-53.